Literature DB >> 7881752

Characterization of alpha 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat.

T J Williams1, D E Clarke.   

Abstract

1. The objective of this study was to investigate the alpha 1-adrenoceptor subtype(s) mediating vasoconstrictor responses to perfused and neuronally-released noradrenaline (NA) in the isolated perfused mesentery preparation of rat. 2. Isolated mesenteric preparations (with gut attached) from male Sprague Dawley rats (250-300g) were perfused via the superior mesenteric artery with oxygenated Krebs solution at approximately 6 ml min-1. The effects of antagonists on vasoconstrictor responses to either perfused (+/-)-NA or periarterial nerve stimulation (70 V, 2 ms pulse width, 10 s train) were determined. 3. Vasoconstrictor responses to perfused NA were antagonized by prazosin (pA2 = 9.3 +/- 0.1), WB4101 (pA2 = 9.6 +/- 0.1), 5-methyl urapidil (5-MU: pA2 = 9.0 +/- 0.1), (+)-niguldipine (insurmountable) and spiperone (pA2 = 7.7 +/- 0.1). The insurmountable nature of the antagonism by (+)-niguldipine (0.1 nM) was greatly reduced by co-perfusion with prazosin (10 nM). Chloroethylclonidine (CEC: 100 microM for 20 min, followed by 40 min washout) caused an approximate twofold increase in the EC50 for (+/-)-NA and reduced the maximum response by approximately 25%. Pre-treatment of tissues with CEC (100 microM as above) did not significantly alter affinity estimates for prazosin (pA2 = 9.2 +/- 0.1), WB4101 (pA2 = 9.3 +/- 0.1) or 5-MU (pA2 = 8.7 +/- 0.2). Vasoconstrictor responses to periarterial nerve stimulation were antagonized by WB4101 > 5-MU > prazosin >> spiperone. CEC (100 microM as above) reduced nerve-stimulated responses by approximately 50%. 4. The affinity estimates for the various antagonists studied suggest that vasoconstrictor responses to both exogenous and neuronally-released NA are mediated via the same a,-adrenoceptor subtype. The pharmacological profile most resembles the 'classical' alpha l A-adrenoceptor, which, in turn, appears to be a rat homologue of the cloned bovine alpha lc-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7881752      PMCID: PMC1510237          DOI: 10.1111/j.1476-5381.1995.tb13259.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Identification of a single alpha 1-adrenoceptor corresponding to the alpha 1A-subtype in rat submaxillary gland.

Authors:  A D Michel; D N Loury; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

2.  Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype.

Authors:  D A Schwinn; J W Lomasney; W Lorenz; P J Szklut; R T Fremeau; T L Yang-Feng; M G Caron; R J Lefkowitz; S Cotecchia
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

3.  5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor.

Authors:  G Gross; G Hanft; C Rugevics
Journal:  Eur J Pharmacol       Date:  1988-07-07       Impact factor: 4.432

4.  Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor.

Authors:  S Cotecchia; D A Schwinn; R R Randall; R J Lefkowitz; M G Caron; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.

Authors:  G Hanft; G Gross
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

6.  (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors.

Authors:  R Boer; A Grassegger; C Schudt; H Glossmann
Journal:  Eur J Pharmacol       Date:  1989-05-11       Impact factor: 4.432

7.  The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder.

Authors:  L Kasakov; G Burnstock
Journal:  Eur J Pharmacol       Date:  1982-12-24       Impact factor: 4.432

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.

Authors:  K P Minneman; C Han; P W Abel
Journal:  Mol Pharmacol       Date:  1988-05       Impact factor: 4.436

10.  Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine.

Authors:  C Han; P W Abel; K P Minneman
Journal:  Mol Pharmacol       Date:  1987-10       Impact factor: 4.436

View more
  12 in total

1.  Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin.

Authors:  R F Schäfers; B Fokuhl; A Wasmuth; H Schumacher; K Taguchi; C de Mey; T Philipp; M C Michel
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

2.  Sympathetic nerve stimulation induces local endothelial Ca2+ signals to oppose vasoconstriction of mouse mesenteric arteries.

Authors:  Lydia W M Nausch; Adrian D Bonev; Thomas J Heppner; Yvonne Tallini; Michael I Kotlikoff; Mark T Nelson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

3.  Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.

Authors:  H Chen; C Fetscher; R F Schäfers; G Wambach; T Philipp; M C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

4.  Existence of different alpha(1)-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteries.

Authors:  X P Yang; S Chiba
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Evidence for involvement of alpha1D-adrenoceptors in contraction of femoral resistance arteries using knockout mice.

Authors:  Joseph Zacharia; Chris Hillier; Akito Tanoue; Gozoh Tsujimoto; Craig J Daly; John C McGrath; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

6.  In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.

Authors:  T J Williams; D R Blue; D V Daniels; B Davis; T Elworthy; J R Gever; M S Kava; D Morgans; F Padilla; S Tassa; R L Vimont; C R Chapple; R Chess-Williams; R M Eglen; D E Clarke; A P Ford
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

7.  Raised tone reveals ATP as a sympathetic neurotransmitter in the porcine mesenteric arterial bed.

Authors:  Amjad Shatarat; William R Dunn; Vera Ralevic
Journal:  Purinergic Signal       Date:  2014-09-18       Impact factor: 3.765

8.  Analysis of the effects of alpha 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery.

Authors:  P H Van der Graaf; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.

Authors:  P Pakdeechote; W R Dunn; V Ralevic
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

10.  Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Authors:  D R Blue; D W Bonhaus; A P Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.